Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
CLGN
#3895
CollPlant Biotechnologies Ltd Ordinary Shares
0.5
7
-1.72%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-1.72%
Changement Mensuel
-70.62%
Evolution sur 6 mois
-79.86%
Changement Annuel
-83.71%
Clôture Précédente
0.5
8
Open
0.5
7
Bid
Ask
Low
0.5
7
High
0.5
7
Volume
1
Marchés
Actions des Marchés US
Soins de Santé
CLGN
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
6.96 M
10.77 M
11.19 M
11.45 M
11.45 M
44.87 M
Valuation ratios
Enterprise value
—
163.33 M
109.87 M
42.61 M
29.33 M
345.14 M
Price to earnings ratio
—
818
-5.62
-9.76
-2.48
—
Price to sales ratio
—
12.52
317.35
6.29
80.07
—
Price to cash flow ratio
—
78.28
6.93
24.94
2.93
—
Price to book ratio
—
4.34
2.94
2.43
3.06
12.77
Enterprise value to EBITDA ratio
—
20.41
-19.03
11.33
-4.87
—
Profitability ratios
Return on assets %
0.53
0
0.45
0.21
0.89
—
Return on equity %
1.29
0.01
0.52
0.25
1.23
—
Return on invested capital %
13 K
1.94
419.83
-2 635.31
-1 658.9
—
Gross margin %
51.08
87.18
33.78
81.83
215.53
—
Operating margin %
91.23
0.42
5 718.06
68.55
3 349.71
—
EBITDA margin %
61.28
51.15
-1 931.44
34.33
-1 170.29
—
Net margin %
94.09
1.52
5 660.54
64.05
3 225.05
—
Liquidity ratios
Quick ratio
1.3
14.6
9.74
8.4
4.29
37.03
Current ratio
1.68
14.96
10.2
8.62
4.44
38.21
Inventory turnover
0.05
0.31
0.24
0.81
0.5
—
Asset turnover
0.57
0.5
0.01
0.3
0.02
—
Solvency ratios
Debt to assets ratio
—
0
1.15
—
—
—
Debt to equity ratio
—
0.01
1.34
—
—
—
Long term debt to total assets ratio
0.31
0
1.14
—
—
—
Long term debt to total equity ratio
0.75
0
1.33
—
—
—
Per share metrics
Operating cash flow per share
—
0.21
1.24
0.24
1.23
—
EBIT per share
—
0.6
-0.71
0.23
-0.62
—
EBITDA per share
—
0.67
-0.52
0.33
-0.53
—
Total debt per share
—
0.02
3.93
—
—
—
Cash per share
—
1.1
2.69
2.34
1.04
7.17
Net current asset value per share
—
3.77
2.87
2.46
1.15
10.25
Tangible book value per share
—
3.75
2.9
2.47
1.16
10.29
Working capital per share
—
3.52
2.59
2.17
0.89
9.17
Book value per share
—
3.77
2.93
2.49
1.18
10.36
Nouvelles
CollPlant secures Korean patent for dermal filler technology
CollPlant lance le kit de bioencre BioFlex pour la bioimpression 3D
CollPlant launches BioFlex bioink kit for 3D bioprinting
La notation des actions CollPlant dégradée à "Conserver" contre "Acheter" par D. Boral Capital
CollPlant stock rating downgraded to Hold from Buy by D. Boral Capital
CollPlant Biotechnologies convoque une assemblée annuelle et extraordinaire pour le 31 décembre
CollPlant Biotechnologies schedules annual and extraordinary meeting for December 31
Le BPA de Collplant ADR a manqué les attentes de 0,41$, le CA en dessous des prévisions
Collplant ADR earnings missed by $0.41, revenue fell short of estimates
Les actions de CollPlant en légère baisse, le chiffre d’affaires du T3 inférieur aux prévisions
CollPlant shares edge down as Q3 revenue falls short of estimates
CollPlant étend sa distribution en Amérique du Nord avec un nouveau hub logistique